FDA Brief

Warning letters Drugs

FDA warning letter to

Jing Cheong Asia Inc. dba New York Tong Ren Tang

High riskIssued Oct 26Posted Nov 3Center for Drug Evaluation and Research (CDER)

New York Tong Ren Tang marketed unapproved new drugs, including eye drops, on its website.

What happened

FDA reviewed the company's website, https://nytrt.com/, in September 2026. It found Ofloxacin Eye Drops, Jingzhi Niuhuang Jiedu Pian, and Gui Pi Wan labeled to treat diseases and concluded they are unapproved new drugs with no FDA-approved applications. The website also offers Notoginseng Formula Special Gout Granule; FDA said prior lab analyses of a similarly named product found undeclared drug ingredients, but it had not sampled this variation.

What FDA found

  1. The website labeling shows Ofloxacin Eye Drops, Jingzhi Niuhuang Jiedu Pian, and Gui Pi Wan are intended to treat diseases or affect body function, making them drugs.

    FD&C Act section 201(g)(1), 21 U.S.C. 321(g)(1); 21 CFR 201.128
  2. FDA says these products are not generally recognized as safe and effective for their labeled uses, so they are new drugs.

    FD&C Act section 201(p), 21 U.S.C. 321(p)
  3. No FDA-approved application is in effect for these products.

    FD&C Act section 505(a), 21 U.S.C. 355(a)
  4. Introducing or delivering these unapproved products for interstate commerce violates the law.

    FD&C Act sections 301(d) and 505(a), 21 U.S.C. 331(d) and 355(a)
  5. The company is responsible for ensuring products it sells do not contain undeclared or potentially harmful ingredients; FDA cited prior analyses of a similarly named gout product that found undeclared drug ingredients.

What FDA wants

FDA tells the company to send a written response to FDAAdvisory@fda.hhs.gov within 15 business days of receipt. The response should include steps taken to correct violations, prevent recurrence, related documentation, and reference number 738200.

Who should pay attention

  • online sellers of imported Chinese medicines
  • brands and distributors of eye drops or herbal drugs
  • consumers using unapproved eye or oral drug products

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk
  4. Natuzem

    FDA warned Mexico-based Natuzem for selling unapproved new drugs, including Reumofan Plus, to U.S. consumers online.

    High risk